Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 7, 2017; 23(45): 8082-8089
Published online Dec 7, 2017. doi: 10.3748/wjg.v23.i45.8082
Published online Dec 7, 2017. doi: 10.3748/wjg.v23.i45.8082
Study ID | Yr | Study period | Type of study | Sample size | IBD patients with active disease | IBD patients with inactive disease | Outcomes |
Disease activity and SGA | |||||||
Bröms et al[19] | 2014 | 2006-2010 | R | 470110 | 988 | 972 | SGA and LBW |
Bush et al[20] | 2004 | 1986-2001 | R | 56514 | 22 | 94 | SGA and LBW |
de Lima-Karagiannis et al[21] | 2016 | 2008-2014 | P | 298 | 92 | 134 | SGA and LBW |
Moser et al[6] | 2000 | 1993-1997 | R | 130 | 13 | 52 | SGA |
Stephansson et al[27] | 2011 | 1994-2006 | R | 871579 | No raw data provided | SGA | |
Mahadevan et al[26] | 2012 | P | 797 | No raw data provided | SGA | ||
Disease activity and LBW | |||||||
Bortlik et al[24] | 2013 | 2007-2012 | R | 41 | 10 | 31 | LBW |
Bröms et al[19] | 2014 | 2006-2010 | R | 470110 | 988 | 972 | SGA and LBW |
Bush et al[20] | 2004 | 1986-2001 | R | 56514 | 22 | 94 | SGA and LBW |
de Lima-Karagiannis et al[21] | 2016 | 2008-2014 | P | 298 | 92 | 134 | SGA and LBW |
Molnár et al[28] | 2010 | R | 167 | No raw data provided | LBW | ||
Bortoli et al[7] | 2011 | 2003-2006 | P | 664 | No raw data provided | LBW | |
Treatment and SGA | Thiopurine exposure | Non thiopurine exposure | |||||
Bröms et al[19] | 2014 | 2006-2010 | R | 470110 | 421 | 1539 | SGA and LBW |
Cleary BJ(23) | 2009 | 1995-2007 | R | 1164030 | 315 | 676 | SGA and LBW |
Treatment and LBW | |||||||
Bröms et al[19] (AZA) | 2014 | 2006-2010 | R | 470110 | 421 | 1539 | SGA and LBW |
Cleary et al[23] | 2009 | 1995-2007 | R | 1164030 | 315 | 1676 | SGA and LBW |
Komoto et al[25] (AZA) | 2016 | 2008-2014 | R | 72 | 7 | 29 | LBW |
Nørgård et al[5] | 2007 | 1996-2004 | R | 900 | 20 | 628 | LBW |
Shim et al[22] | 2011 | 1996-2006 | R | 93 | 19 | 74 | LBW |
Nørgård et al[10] | 2003 | 1991-2000 | R | 19437 | No raw data provided | LBW |
Study | Active or inactive disease definition |
Bröms et al[19] | Any change in the treatment |
Bush et al[20] | Hospitalization |
Moser et al[6] | Surgery due to a flare of the disease |
Shim et al[22] | |
de Lima-Karagiannis et al[21] | HBI > 5 |
Komoto et al[25] | SCCAI > 2; Partial Mayo Score Fecal calprotectin > 200 microgr/gr |
Bortlik et al[24] | Consideration of treating physician |
- Citation: Gonzalez-Suarez B, Sengupta S, Moss AC. Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis. World J Gastroenterol 2017; 23(45): 8082-8089
- URL: https://www.wjgnet.com/1007-9327/full/v23/i45/8082.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i45.8082